Insider · CIK 0001822629
Nikhil Lalwani
Files at ANIP (ANI PHARMACEUTICALS INC). First filing Nov 27, 2024, latest Sep 16, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANIP: ANI PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | ANI PHARMACEUTICALS INC | $383k 5,400 shares | -2% | +3% from low-27% from high | |
| 70Notable | ANI PHARMACEUTICALS INC | $4.9M 56,960 shares | -12% | +66% from low0% from high | |
| 50Moderate | ANI PHARMACEUTICALS INC | $1.9M 33,481 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -5,400 | $71.00 | $383k | 339,089 | 26 d ago |
| Aug 12, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -56,960 | $85.93 | $4.9M | 411,219 | Aug 14, 2025 |
| Mar 23, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -17,455 | $64.26 | $1.1M | 468,179 | Mar 25, 2025 |
| Mar 7, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -17,060 | $60.62 | $1.0M | 485,634 | Mar 14, 2025 |
| Feb 28, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -12,216 | $61.89 | $756k | 502,694 | Mar 4, 2025 |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +91,399 | $0.00 | $0 | 461,777 | Feb 18, 2025 |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +60,932 | $0.00 | $0 | 522,709 | Feb 18, 2025 |
| Feb 14, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -7,799 | $58.92 | $460k | 514,910 | Feb 18, 2025 |
| Nov 26, 2024 | ANIP ANI PHARMACEUTICALS INC | MOption exercise Common Stock | +30,000 | $29.00 | $870k | 403,859 | Nov 27, 2024 |
| Nov 26, 2024 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -30,000 | $57.95 | $1.7M | 373,859 | Nov 27, 2024 |
| Nov 26, 2024 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -3,481 | $58.30 | $203k | 370,378 | Nov 27, 2024 |
| Nov 26, 2024 | ANIP ANI PHARMACEUTICALS INC | MOption exercise Stock Option (right to buy)derivative | -30,000 | $29.00 | $870k | 138,027 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.